Maternal vitamin D deficiency causes smaller muscle fibers and altered transcript levels of genes involved in protein degradation, myogenesis, and cytoskeleton organization in the newborn rat

Molecular Nutrition and Food Research

Volumn 58, Issue 2, 2014, Pages 343-352

  Max, Daniela ^a   Brandsch, Corinna ^a   Schumann, Sarah ^a   Kühne, Hagen ^a   Frommhagen, Matthias ^a   Schutkowski, Alexandra ^a   Hirche, Frank ^a   Staege, Martin S ^a   Stangl, Gabriele I ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Maternal vitamin D deficiency; Offspring; Rat; Skeletal muscle; Transcript profiling

Indexed keywords

COLECALCIFEROL; TRANSCRIPTOME;

ANIMAL; ARTICLE; BLOOD; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOSKELETON; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; MATERNAL NUTRITION; MATERNAL VITAMIN D DEFICIENCY; METABOLISM; MUSCLE DEVELOPMENT; NEWBORN; PATHOLOGY; PHYSIOLOGY; PREGNANCY; PROGENY; PROTEIN DEGRADATION; RAT; SKELETAL MUSCLE; SPRAGUE DAWLEY RAT; TRANSCRIPT PROFILING; VITAMIN D DEFICIENCY;

MATERNAL VITAMIN D DEFICIENCY; OFFSPRING; RAT; SKELETAL MUSCLE; TRANSCRIPT PROFILING;

ANIMALS; ANIMALS, NEWBORN; CELL DIFFERENTIATION; CELL PROLIFERATION; CHOLECALCIFEROL; CYTOSKELETON; FEMALE; GENE EXPRESSION REGULATION; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; MUSCLE DEVELOPMENT; MUSCLE FIBERS, SKELETAL; PREGNANCY; PROTEOLYSIS; RATS; RATS, SPRAGUE-DAWLEY; TRANSCRIPTOME; VITAMIN D DEFICIENCY;

EID: 84893370551     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201300360     Document Type: Article

References (44)

1. DeLuca, H. F., Overview of general physiologic features and functions of vitamin D. Am. J. Clin. Nutr. 2004, 80, 1689S-1696S.
2. Bischoff-Ferrari, H. A., Dietrich, T., Orav, E. J., Hu, F. B. et al., Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or = 60 y. Am. J. Clin. Nutr. 2004, 80, 752-758.
3. Visser, M., Deeg, D. J., Lips, P., Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J. Clin. Endocrinol. Metab. 2003, 88, 5766-5772.
4. Snijder, M. B., van Schoor, N. M., Pluijm, S. M., van Dam, R. M. et al., Vitamin D status in relation to one-year risk of recurrent falling in older men and women. J. Clin. Endocrinol. Metab. 2006, 91, 2980-2985.
5. Bischoff-Ferrari, H. A., Dawson-Hughes, B., Willett, W. C., Staehelin, H. B. et al., Effect of Vitamin D on falls: a meta-analysis. JAMA 2004, 291, 1999-2006.
6. 3 stimulates myogenic differentiation by inhibiting cell proliferation and modulating the expression of promyogenic growth factors and myostatin in C2C12 skeletal muscle cells. Endocrinology 2011, 152, 2976-2986.
7. Endo, I., Inoue, D., Mitsui, T., Umaki, Y. et al., Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myo-regulatory transcription factors. Endocrinology 2003, 144, 5138-5144.
8. Ginde, A. A., Liu, M. C., Camargo, C. A., Jr., Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch. Intern. Med. 2009, 169, 626-632.
9. Gonzalez-Gross, M., Valtuena, J., Breidenassel, C., Moreno, L. A. et al., Vitamin D status among adolescents in Europe: the Healthy Lifestyle in Europe by Nutrition in Adolescence study. Br. J. Nutr. 2012, 107, 755-764.
10. Basile, L. A., Taylor, S. N., Wagner, C. L., Quinones, L. et al., Neonatal vitamin D status at birth at latitude 32 degrees 72': evidence of deficiency. J. Perinatol. 2007, 27, 568-571.
11. Merewood, A., Mehta, S. D., Grossman, X., Chen, T. C. et al., Widespread vitamin D deficiency in urban Massachusetts newborns and their mothers. Pediatrics 2010, 125, 640-647.
12. Bodnar, L. M., Simhan, H. N., Powers, R. W., Frank, M. P. et al., High prevalence of vitamin D insufficiency in black and white pregnant women residing in the northern United States and their neonates. J. Nutr. 2007, 137, 447-452.
13. Lee, J. M., Smith, J. R., Philipp, B. L., Chen, T. C. et al., Vitamin D deficiency in a healthy group of mothers and newborn infants. Clin. Pediatr. 2007, 46, 42-44.
14. Buckingham, M., Vincent, S. D., Distinct and dynamic myogenic populations in the vertebrate embryo. Curr. Opin. Genet. Dev. 2009, 19, 444-453.
15. Buckingham, M., Skeletal muscle formation in vertebrates. Curr. Opin. Genet. Dev. 2001, 11, 440-448.
16. Reeves, P. G., Nielsen, F. H., Fahey, G. C., Jr., AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 1993, 123, 1939-1951.
17. 3: a noninvasive tool for the assessment of vitamin D status. Anal. Bioanal. Chem. 2008, 391, 229-238.
18. Schmidt, N., Brandsch, C., Kühne, H., Thiele, A. et al., Vitamin D receptor deficiency and low vitamin D diet stimulate aortic calcification and osteogenic key factor expression in mice. PLoS One 2012, 7, e35316.
19. Mattila, P. H., Piironen, V. I., Uusi-Rauva, E. J., Koivistoinen, P. E., Contents of cholecalciferol, ergocalciferol, and their 25-hydroxylated metabolites in milk products and raw meat and liver as determined by HPLC. J. Agric. Food Chem. 1995, 43, 2394-2399.
20. Bassler, R., Buchholz, H., Die chemische Untersuchung von Futtermitteln. Buch III. VDLUFA Verlag, Darmstadt 1976.
21. Huang da, W., Sherman, B. T., Lempicki, R. A., Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4, 44-57.
22. Huang da, W., Sherman, B. T., Lempicki, R. A., Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009, 37, 1-13.
23. Bettzieche, A., Brandsch, C., Eder, K., Stangl, G. I., Lupin protein acts hypocholesterolemic and increases milk fat content in lactating rats by influencing the expression of genes involved in cholesterol homeostasis and triglyceride synthesis. Mol. Nutr. Food Res. 2009, 53, 1134-1142.
24. Pfaffl, M. W., A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29, e45.
25. Girgis, C. M., Clifton-Bligh, R. J., Hamrick, M. W., Holick, M. F. et al., The roles of vitamin D in skeletal muscle: form, function, and metabolism. Endocr. Rev. 2013, 34, 33-83.
26. Yan, X. X., Zhu, M. J., Dodson, M. V., Du, M., Developmental programming of fetal skeletal muscle and adipose tissue development. J. Genomics 2012, 1, 29-38.
27. Yoshikawa, S., Nakamura, T., Tanabe, H., Imamura, T., Osteomalacic myopathy. Endocrinol. Jpn. 1979, 26, 65-72.
28. Glickman, M. H., Ciechanover, A., The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 2002, 82, 373-428.
29. Lecker, S. H., Solomon, V., Mitch, W. E., Goldberg, A. L., Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. J. Nutr. 1999, 129, 227S-237S.
30. Attaix, D., Aurousseau, E., Combaret, L., Kee, A. et al., Ubiquitin-proteasome-dependent proteolysis in skeletal muscle. Reprod. Nutr. Dev. 1998, 38, 153-165.
31. Hasselgren, P. O., Wray, C., Mammen, J., Molecular regulation of muscle cachexia: it may be more than the proteasome. Biochem. Biophys. Res. Commun. 2002, 290, 1-10.
32. Lassar, A. B., Skapek, S. X., Novitch, B., Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. Curr. Opin. Cell. Biol. 1994, 6, 788-794.
33. Molkentin, J. D., Olson, E. N., Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors. Proc. Natl. Acad. Sci. USA 1996, 93, 9366-9373.
34. Miyamoto, S., Hidaka, K., Jin, D., Morisaki, T., RNA-binding proteins Rbm38 and Rbm24 regulate myogenic differentiation via p21-dependent and -independent regulatory pathways. Genes Cells 2009, 14, 1241-1252.
35. James, P. L., Stewart, C. E., Rotwein, P., Insulin-like growth factor binding protein-5 modulates muscle differentiation through an insulin-like growth factor-dependent mechanism. J. Cell. Biol. 1996, 133, 683-693.
36. Salih, D. A., Tripathi, G., Holding, C., Szestak, T. A. et al., Insulin-like growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in mice. Proc. Natl. Acad. Sci. USA 2004, 101, 4314-4319.
37. Zhao, P., Hoffman, E. P., Embryonic myogenesis pathways in muscle regeneration. Dev. Dyn. 2004, 229, 380-392.
38. Parakati, R., DiMario, J. X., Dynamic transcriptional regulatory complexes, including E2F4, p107, p130, and Sp1, control fibroblast growth factor receptor 1 gene expression during myogenesis. J. Biol. Chem. 2005, 280, 21284-21294.
39. Martin-Davila, P., Fortun, J., Gutierrez, C., Marti-Belda, P. et al., Analysis of a quantitative PCR assay for CMV infection in liver transplant recipients: an intent to find the optimal cut-off value. J. Clin. Virol. 2005, 33, 138-144.
40. Taylor, J. G. 6th, Cheuk, A. T., Tsang, P. S., Chung, J. Y. et al., Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models. J. Clin. Invest. 2009, 119, 3395-3407.
41. Yu, Y., Khan, J., Khanna, C., Helman, L. et al., Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat. Med. 2004, 10, 175-181.
42. Huang, P., Zhao, X. S., Fields, M., Ransohoff, R. M. et al., Imatinib attenuates skeletal muscle dystrophy in mdx mice. FASEB J. 2009, 23, 2539-2548.
43. Michel, R. N., Dunn, S. E., Chin, E. R., Calcineurin and skeletal muscle growth. Proc. Nutr. Soc. 2004, 63, 341-349.
44. Kitzing, T. M., Wang, Y., Pertz, O., Copeland, J. W. et al., Formin-like 2 drives amoeboid invasive cell motility downstream of RhoC. Oncogene 2010, 29, 2441-2448.